drugset / Trial / NCT02382718
FAST Fish Phase IIb Clinical Trial for the Treatment of Fish Allergy by Subcutaneous Immunotherapy
Phase 2
Completed
45 enrolled
George Stavroulakis
Hospital Regional de Malaga · collabHospital San Carlos, Madrid · collabHospital Universitario Reina Sofia de Cordoba · collabLandspitali University Hospital · collabMedical University of Lodz · collabNational University Hospital NUHD Denmark · collabNational and Kapodistrian University of Athens · collabOdense University Hospital · collabUMC Utrecht · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a phase IIb clinical trial to investigate the efficacy and safety of subcutaneous immunotherapy with a modified parvalbumin called mCyp c 1 for the treatment of fish allergy to subjects allergic to fish.
Timeline
- Start
- 2015-10
- Primary completion
- 2017-02
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mCyp c 1 | Protein / enzyme biologic | 60 ug | Subcutaneous |